Warby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) P/B ratio
As of 5 November 2026, Warby Parker Inc. (WRBY) trades at a P/B ratio of 8.1×. Over the past ten years it has ranged from 0.0× (September 2021) to 14.0× (April 2022); the current reading is higher than 72% of that period. That is above the Medical Instruments & Supplies industry median of 2.3× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 7.3× | (15.18%) |
| FY2024 | 8.6× | 47.87% |
| FY2023 | 5.8× | 0.86% |
| FY2022 | 5.7× | (50.46%) |
| FY2021 | 11.6× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 8.6× | (10.46%) |
| Jun 2026 | 9.6× | 38.61% |
| Mar 2026 | 6.9× | (4.79%) |
| Dec 2025 | 7.3× | (20.77%) |
| 22 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| AZTA Azenta, Inc. compare | 1.1× |
| XRAY DENTSPLY SIRONA Inc. compare | 1.5× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.0× |
| LMAT LeMaitre Vascular, Inc. compare | 4.4× |
| ATRC AtriCure, Inc. compare | 5.6× |
| KMTS Kestra Medical Technologies, Ltd. compare | 7.4× |
| WRBY Warby Parker Inc. | 8.1× |
| PLSE Pulse Biosciences, Inc compare | 20.8× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on WRBY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement